Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hey what you said is true regarding news penetration. I think this will be trading above .01 soon. They also are going to have audited financials soon with current status. Watch out folks.
This news does not appear to have penetrated the market yet. Wait until everyone catches up
Lans Holdings Successfully Completes Due Diligence of Global Stem Cells Group
MIAMI, FL, July 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - Lans Holdings Inc. is pleased to announce that it has successfully completed its due diligence as per the binding letter of intent to acquire 100% of Global Stem Cells Group Inc (GSCG).
"We are very pleased to have successfully completed our due diligence," said Dave Christensen, CEO of Lans Holdings, "And we are looking forward to the closing of the acquisition."
The company has engaged Fruci & Associates as its auditors as it moves forward to complete its audits and reviews of its financials to bring the company back to current status.
This press release should be read in conjunction with the 8K filed on July 29, 2019 on www.sec.gov
http://m.nasdaq.com/article/lans-holdings-successfully-completes-due-diligence-of-global-stem-cells-group-20190729-00516
Wow. Just woke up and still catching up. This news is amazing. Looks like this is a done deal pretty much.
On 7/10/19, PennyProOTC received this email from LAHO IR stating that their immediate focus was on getting filings current with SEC and completing the GSCG acquisition per the binding LOI.
https://investorshub.advfn.com/boards/m_read_msg.aspx?message_id=149837500
https://investorshub.advfn.com/boards/m_read_msg.aspx?message_id=149837261
Thanks for sharing that yesterday.
$LAHO DD - R/M binding LOI Signed for Lans Holdings to acquire Global Stem Cells Group (GSCG)
***Awaiting announcement of return to SEC current status by Sept 12 - (within 90 days from June 12 PR as announced)
***Awaiting Reverse Merger filing of asset acquisition definitive agreement expected before October 31st (150 days from the May 29th binding LOI 8k filed)
Comprehensive LAHO DD - https://investorshub.advfn.com/boards/m_read_msg.aspx?message_id=150088117
GSCG has 36 stem cell centers in 27 countries globally, plus the Adimarket which sells products and recently outfits a medical center exclusively. This adds another revenue stream in addition to the work of its centers administering stem cell therapies and training medical professionals, and another way this company can scale and expand within the industry. There are a lot of facets to take in when assessing the potential this company has in a hot, growing sector.
“Global Stem Cells Group was founded in 2010 by Benito Novas, an entrepreneur who became intrigued by advancements being made in the field of stem cell medicine. Determined to make these advancements available to as many patients as possible, Mr. Novas grew GSCG from humble beginnings to the company’s current status as a key player in promoting point of care regenerative medicine therapies worldwide.
Global Stem Cells Group administers a constant flow of knowledge and innovation regarding the role of stem cells in modern medicine. The company’s aim is to accelerate the process of getting promising stem cell research and technology developed into treatments and therapies, and made available to physicians and patients. We focus specifically on stem cell research as a source of potential treatments for a wide range of conditions and diseases—in fact, we strongly believe that stem cell and regenerative medicine protocols are the future of modern medicine. GSCG works closely with patients, educators, physicians, regulators and policy makers to foster engagement and develop materials that promote stem cell technology.
As a worldwide network, Global Stem Cells Group combines six major medical corporations, each focused on furthering the industry’s scientific and technological advancements to lead cutting edge stem cell development, treatments and training, while adhering to the highest medical standards. The combined efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions.”
Comprehensive $LAHO DD - next penny runner:
***Awaiting announcement of return to SEC current status by Sept 12 - (within 90 days from June 12 PR as announced)
***Awaiting Reverse Merger filing of asset acquisition definitive agreement expected before October 31st (150 days from the May 29th binding LOI 8k filed)
—————————————————-
REVERSE MERGER ANNOUNCEMENT
Lans Holdings Enters into Binding LOI to Acquire Global Stem Cells Group (GSCG)
https://globenewswire.com/news-release/2019/05/28/1853115/0/en/Lans-Holdings-Enters-into-Binding-LOI-to-Acquire-Global-Stem-Cells-Group.html
SEC FORM 8K (Binding LOI to acquire GSCG)
https://www.otcmarkets.com/filing/html?id=13457482&guid=
GSCG has 41 stem cell centers in 25 countries globally, plus the Adimarket which sells stem cell proprietary technology and products and recently outfitted a medical center exclusively. This adds another revenue stream in addition to the work of its centers administering stem cell therapies and training medical professionals, and another way this company can scale and expand within the industry. There are a lot of facets to take in when assessing the potential this company has in a hot, growing sector.
Benito Novas of Aesthetica Marketing Group Set as Keynote for Chilean Aesthetics Congress (JULY 17, 2019)
http://www.stemcellsgroup.com/adimarket-llc-launches-new-product-for-physicians-seeking-to-create-regenerative-medicine-and-stem-cell-treatment-centers-2/
Adimarket, LLC Launches New Product for Physicians Seeking to Create Regenerative Medicine and Stem Cell Treatment Centers (JULY 17, 2019)
http://www.stemcellsgroup.com/adimarket-llc-launches-new-product-for-physicians-seeking-to-create-regenerative-medicine-and-stem-cell-treatment-centers/
GSCG: Stem Cells Group to Host Regenerative Medicine Symposium at the University of Miami (June 26, 2019)
http://www.stemcellsgroup.com/stem-cells-group-to-host-regenerative-medicine-symposium-at-the-university-of-miami/
GSCG: Global Stem Cells Group to Host Argentina Lectures on Newest Stem Cells Therapies (June 26, 2019)
http://www.stemcellsgroup.com/global-stem-cells-group-to-host-argentina-lectures-on-newest-stem-cells-therapies/
GSCG: ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center: The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France. GSCG’s Adimarket store will all provide equipment and supplies to the facility. (June 26, 2019)
http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/
To learn more about Churchill Aesthetic Center, visit https://www.churchill-aesthetic-center.be/. To learn more about ISSCA, visit https://issca.us/
LAHO: Global Stem Cells Group Announces Opening of Two New Stem Cell Centers (June 12, 2019)
https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503
GLOBAL STEM CELLS GROUP WEBSITE--GSCG
http://www.stemcellsgroup.com/
GSCG HAS AN ONLINE STORE FOR REGENERATIVE MEDICINE PRACTITIONERS
GSCG REVENUE ($29 million):
https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775
GSCG--Adimarket - Turn-Key Solution for Regenerative Medicine
https://www.adimarket.net/
Zoominfo says that Adimart, Inc (Adimarket, Inc., a division of the Global Stem Cells Group, is a cost-competitive online marketplace for quality regenerative medicine equipment and supplies) has $10 million in revenue with a breakdown of 2.4 million average quarterly in 2018.
https://www.zoominfo.com/c/adimarket-inc/359689609
Lans Holdings posted a message about the LOI on its Linked in
https://www.linkedin.com/company/lans-holdings-inc?trk=similar-companies_org_title
CEO Benito Novas has some impressive credentials and accolades
https://www.linkedin.com/in/benito-novas-671a4122?trk=org-employees_mini-profile_title
Here’s the YouTube channel for GSCG (videos of CEO speaking, conferences, explanations of the company and its processes, etc)
https://www.youtube.com/user/StemCellsGroup
$LAHO DD - great entry - Binding LOI Reverse Merger with GSCG - filed as an 8K
****Reverse Merger DD satisfaction statement & asset acquisition definitive agreement expected any day now by October 31st! (150 days from binding LOI filed as an SEC 8k on May 28th)
Comprehensive LAHO DD - https://investorshub.advfn.com/boards/m_read_msg.aspx?message_id=150088117
LAHO/GSCG - When Dilution Is A Buy Signal
https://seekingalpha.com/article/1787022-when-dilution-is-a-buy-signal
Try the GSCG Bible. The book of Benito is a great read:
https://www.linkedin.com/in/benito-novas-671a4122?trk=org-employees_mini-profile_title
https://www.youtube.com/user/StemCellsGroup
The REAL apostle is GSCG CEO Benito Novas - delivering his message, teachings, and training of stem cell procedures and treatments to communities on an international level.
GSCG has 41 stem cell centers in 25 countries globally, plus the Adimarket which sells stem cell proprietary technology and products and recently outfitted a medical center exclusively. This adds another revenue stream in addition to the work of its centers administering stem cell therapies and training medical professionals, and another way this company can scale and expand within the industry. There are a lot of facets to take in when assessing the potential this company has in a hot, growing sector.
“Global Stem Cells Group was founded in 2010 by Benito Novas, an entrepreneur who became intrigued by advancements being made in the field of stem cell medicine. Determined to make these advancements available to as many patients as possible, Mr. Novas grew GSCG from humble beginnings to the company’s current status as a key player in promoting point of care regenerative medicine therapies worldwide.
Global Stem Cells Group administers a constant flow of knowledge and innovation regarding the role of stem cells in modern medicine. The company’s aim is to accelerate the process of getting promising stem cell research and technology developed into treatments and therapies, and made available to physicians and patients. We focus specifically on stem cell research as a source of potential treatments for a wide range of conditions and diseases—in fact, we strongly believe that stem cell and regenerative medicine protocols are the future of modern medicine. GSCG works closely with patients, educators, physicians, regulators and policy makers to foster engagement and develop materials that promote stem cell technology.
As a worldwide network, Global Stem Cells Group combines six major medical corporations, each focused on furthering the industry’s scientific and technological advancements to lead cutting edge stem cell development, treatments and training, while adhering to the highest medical standards. The combined efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions.”
Comprehensive LAHO DD - https://investorshub.advfn.com/boards/m_read_msg.aspx?message_id=150088117
Yes! Only a few more posted before the mandatory muzzle for the rest of the day. Please do continue to spew outright ridiculous lies about a good company like LAHO/GSCG. We are all excited that many care so much about a so-called scam stock & employees of a so-called scam stock that are complete strangers. But Hanna-Barbera Productions called me and said they don’t appreciate usage of their characters’ names in efforts to scam LAHO investors with cheesy stories of horrible fiction. Jesus also called and said none of his apostles should be doing that to a gift ticker like LAHO (soon to be GSCG).
$LAHO DD - R/M binding LOI Signed for Lans Holdings to acquire Global Stem Cells Group (GSCG)
***Awaiting announcement of return to SEC current status by Sept 12 - (within 90 days from June 12 PR as announced)
***Awaiting Reverse Merger filing of asset acquisition definitive agreement expected before October 31st (150 days from the May 29th binding LOI 8k filed)
Comprehensive LAHO DD - https://investorshub.advfn.com/boards/m_read_msg.aspx?message_id=150088117
GSCG has 36 stem cell centers in 27 countries globally, plus the Adimarket which sells products and recently outfits a medical center exclusively. This adds another revenue stream in addition to the work of its centers administering stem cell therapies and training medical professionals, and another way this company can scale and expand within the industry. There are a lot of facets to take in when assessing the potential this company has in a hot, growing sector.
“Global Stem Cells Group was founded in 2010 by Benito Novas, an entrepreneur who became intrigued by advancements being made in the field of stem cell medicine. Determined to make these advancements available to as many patients as possible, Mr. Novas grew GSCG from humble beginnings to the company’s current status as a key player in promoting point of care regenerative medicine therapies worldwide.
Global Stem Cells Group administers a constant flow of knowledge and innovation regarding the role of stem cells in modern medicine. The company’s aim is to accelerate the process of getting promising stem cell research and technology developed into treatments and therapies, and made available to physicians and patients. We focus specifically on stem cell research as a source of potential treatments for a wide range of conditions and diseases—in fact, we strongly believe that stem cell and regenerative medicine protocols are the future of modern medicine. GSCG works closely with patients, educators, physicians, regulators and policy makers to foster engagement and develop materials that promote stem cell technology.
As a worldwide network, Global Stem Cells Group combines six major medical corporations, each focused on furthering the industry’s scientific and technological advancements to lead cutting edge stem cell development, treatments and training, while adhering to the highest medical standards. The combined efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions.”
$$$LAHO DD - Binding LOI Reverse Merger with GSCG - filed as an 8K
***Announcement of return to SEC current status expected by Sept 12 - (within 90 days from June 12 PR as announced)
***Reverse Merger filing of asset acquisition definitive agreement expected before October 31st (150 days from the May 29th binding LOI 8k filed)
Comprehensive LAHO DD - https://investorshub.advfn.com/boards/m_read_msg.aspx?message_id=150088117
Comprehensive $LAHO DD - next penny runner:
***Awaiting announcement of return to SEC current status by Sept 12 - (within 90 days from June 12 PR as announced)
***Awaiting Reverse Merger filing of asset acquisition definitive agreement expected before October 31st (150 days from the May 29th binding LOI 8k filed)
—————————————————-
REVERSE MERGER ANNOUNCEMENT
Lans Holdings Enters into Binding LOI to Acquire Global Stem Cells Group (GSCG)
https://globenewswire.com/news-release/2019/05/28/1853115/0/en/Lans-Holdings-Enters-into-Binding-LOI-to-Acquire-Global-Stem-Cells-Group.html
SEC FORM 8K (Binding LOI to acquire GSCG)
https://www.otcmarkets.com/filing/html?id=13457482&guid=
GSCG has 41 stem cell centers in 25 countries globally, plus the Adimarket which sells stem cell proprietary technology and products and recently outfitted a medical center exclusively. This adds another revenue stream in addition to the work of its centers administering stem cell therapies and training medical professionals, and another way this company can scale and expand within the industry. There are a lot of facets to take in when assessing the potential this company has in a hot, growing sector.
Benito Novas of Aesthetica Marketing Group Set as Keynote for Chilean Aesthetics Congress (JULY 17, 2019)
http://www.stemcellsgroup.com/adimarket-llc-launches-new-product-for-physicians-seeking-to-create-regenerative-medicine-and-stem-cell-treatment-centers-2/
Adimarket, LLC Launches New Product for Physicians Seeking to Create Regenerative Medicine and Stem Cell Treatment Centers (JULY 17, 2019)
http://www.stemcellsgroup.com/adimarket-llc-launches-new-product-for-physicians-seeking-to-create-regenerative-medicine-and-stem-cell-treatment-centers/
GSCG: Stem Cells Group to Host Regenerative Medicine Symposium at the University of Miami (June 26, 2019)
http://www.stemcellsgroup.com/stem-cells-group-to-host-regenerative-medicine-symposium-at-the-university-of-miami/
GSCG: Global Stem Cells Group to Host Argentina Lectures on Newest Stem Cells Therapies (June 26, 2019)
http://www.stemcellsgroup.com/global-stem-cells-group-to-host-argentina-lectures-on-newest-stem-cells-therapies/
GSCG: ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center: The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France. GSCG’s Adimarket store will all provide equipment and supplies to the facility. (June 26, 2019)
http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/
To learn more about Churchill Aesthetic Center, visit https://www.churchill-aesthetic-center.be/. To learn more about ISSCA, visit https://issca.us/
LAHO: Global Stem Cells Group Announces Opening of Two New Stem Cell Centers (June 12, 2019)
https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503
GLOBAL STEM CELLS GROUP WEBSITE--GSCG
http://www.stemcellsgroup.com/
GSCG HAS AN ONLINE STORE FOR REGENERATIVE MEDICINE PRACTITIONERS
GSCG REVENUE ($29 million):
https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775
GSCG--Adimarket - Turn-Key Solution for Regenerative Medicine
https://www.adimarket.net/
Zoominfo says that Adimart, Inc (Adimarket, Inc., a division of the Global Stem Cells Group, is a cost-competitive online marketplace for quality regenerative medicine equipment and supplies) has $10 million in revenue with a breakdown of 2.4 million average quarterly in 2018.
https://www.zoominfo.com/c/adimarket-inc/359689609
Lans Holdings posted a message about the LOI on its Linked in
https://www.linkedin.com/company/lans-holdings-inc?trk=similar-companies_org_title
CEO Benito Novas has some impressive credentials and accolades
https://www.linkedin.com/in/benito-novas-671a4122?trk=org-employees_mini-profile_title
Here’s the YouTube channel for GSCG (videos of CEO speaking, conferences, explanations of the company and its processes, etc)
https://www.youtube.com/user/StemCellsGroup
LAHO/GSCG - A Very Logical Post from AllinFun - Post #24754
<<Ask yourselves - why would Global Stem Cells Group involve themselves into a pump and dump scam? Why would they sacrifice their public reputation over a million or 2 million dollars in a share selling scam? That would destroy their hopes of going public successfully with growth in the future and get themselves into a scandal that is definitely not worth the couple million at most to be made in diluting shares. Also its been posted all over their website since its announcement. Again no company with 100+ million in revs annually with huge YOY growth would involve themselves in that type of scandal and destroy their PR. This is very simply logic.>>
LAHO- ***TAG: LANS HOLDINGS on GSCG website
https://www.stemcellsgroup.com/tag/lans-holdings/
Comprehensive $LAHO DD - next penny runner:
***Awaiting announcement of return to SEC current status by Sept 12 - (within 90 days from June 12 PR as announced)
***Awaiting Reverse Merger filing of asset acquisition definitive agreement expected before October 31st (150 days from the May 29th binding LOI 8k filed)
—————————————————-
REVERSE MERGER ANNOUNCEMENT
Lans Holdings Enters into Binding LOI to Acquire Global Stem Cells Group (GSCG)
https://globenewswire.com/news-release/2019/05/28/1853115/0/en/Lans-Holdings-Enters-into-Binding-LOI-to-Acquire-Global-Stem-Cells-Group.html
SEC FORM 8K (Binding LOI to acquire GSCG)
https://www.otcmarkets.com/filing/html?id=13457482&guid=
GSCG has 41 stem cell centers in 25 countries globally, plus the Adimarket which sells stem cell proprietary technology and products and recently outfitted a medical center exclusively. This adds another revenue stream in addition to the work of its centers administering stem cell therapies and training medical professionals, and another way this company can scale and expand within the industry. There are a lot of facets to take in when assessing the potential this company has in a hot, growing sector.
Benito Novas of Aesthetica Marketing Group Set as Keynote for Chilean Aesthetics Congress (JULY 17, 2019)
http://www.stemcellsgroup.com/adimarket-llc-launches-new-product-for-physicians-seeking-to-create-regenerative-medicine-and-stem-cell-treatment-centers-2/
Adimarket, LLC Launches New Product for Physicians Seeking to Create Regenerative Medicine and Stem Cell Treatment Centers (JULY 17, 2019)
http://www.stemcellsgroup.com/adimarket-llc-launches-new-product-for-physicians-seeking-to-create-regenerative-medicine-and-stem-cell-treatment-centers/
GSCG: Stem Cells Group to Host Regenerative Medicine Symposium at the University of Miami (June 26, 2019)
http://www.stemcellsgroup.com/stem-cells-group-to-host-regenerative-medicine-symposium-at-the-university-of-miami/
GSCG: Global Stem Cells Group to Host Argentina Lectures on Newest Stem Cells Therapies (June 26, 2019)
http://www.stemcellsgroup.com/global-stem-cells-group-to-host-argentina-lectures-on-newest-stem-cells-therapies/
GSCG: ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center: The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France. GSCG’s Adimarket store will all provide equipment and supplies to the facility. (June 26, 2019)
http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/
To learn more about Churchill Aesthetic Center, visit https://www.churchill-aesthetic-center.be/. To learn more about ISSCA, visit https://issca.us/
LAHO: Global Stem Cells Group Announces Opening of Two New Stem Cell Centers (June 12, 2019)
https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503
GLOBAL STEM CELLS GROUP WEBSITE--GSCG
http://www.stemcellsgroup.com/
GSCG HAS AN ONLINE STORE FOR REGENERATIVE MEDICINE PRACTITIONERS
GSCG REVENUE ($29 million):
https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775
GSCG--Adimarket - Turn-Key Solution for Regenerative Medicine
https://www.adimarket.net/
Zoominfo says that Adimart, Inc (Adimarket, Inc., a division of the Global Stem Cells Group, is a cost-competitive online marketplace for quality regenerative medicine equipment and supplies) has $10 million in revenue with a breakdown of 2.4 million average quarterly in 2018.
https://www.zoominfo.com/c/adimarket-inc/359689609
Lans Holdings posted a message about the LOI on its Linked in
https://www.linkedin.com/company/lans-holdings-inc?trk=similar-companies_org_title
CEO Benito Novas has some impressive credentials and accolades
https://www.linkedin.com/in/benito-novas-671a4122?trk=org-employees_mini-profile_title
Here’s the YouTube channel for GSCG (videos of CEO speaking, conferences, explanations of the company and its processes, etc)
https://www.youtube.com/user/StemCellsGroup
$LAHO DD - great entry - Binding LOI Reverse Merger with GSCG - filed as an 8K
****Reverse Merger DD satisfaction statement & asset acquisition definitive agreement expected any day now by October 31st! (150 days from binding LOI filed as an SEC 8k on May 28th)
Comprehensive LAHO DD - https://investorshub.advfn.com/boards/m_read_msg.aspx?message_id=150088117
$LAHO DD - great entry point - R/M binding LOI Signed for Lans Holdings to acquire Global Stem Cells Group (GSCG)!
**Reverse Merger asset acquisition definitive agreement expected any day by October 31st! (150 days from May 28th 8K filing of binding LOI)
Comprehensive LAHO DD - https://investorshub.advfn.com/boards/m_read_msg.aspx?message_id=150088117
GSCG has 36 stem cell centers in 27 countries globally, plus the Adimarket which sells products and recently outfits a medical center exclusively. This adds another revenue stream in addition to the work of its centers administering stem cell therapies and training medical professionals, and another way this company can scale and expand within the industry. There are a lot of facets to take in when assessing the potential this company has in a hot, growing sector.
“Global Stem Cells Group was founded in 2010 by Benito Novas, an entrepreneur who became intrigued by advancements being made in the field of stem cell medicine. Determined to make these advancements available to as many patients as possible, Mr. Novas grew GSCG from humble beginnings to the company’s current status as a key player in promoting point of care regenerative medicine therapies worldwide.
Global Stem Cells Group administers a constant flow of knowledge and innovation regarding the role of stem cells in modern medicine. The company’s aim is to accelerate the process of getting promising stem cell research and technology developed into treatments and therapies, and made available to physicians and patients. We focus specifically on stem cell research as a source of potential treatments for a wide range of conditions and diseases—in fact, we strongly believe that stem cell and regenerative medicine protocols are the future of modern medicine. GSCG works closely with patients, educators, physicians, regulators and policy makers to foster engagement and develop materials that promote stem cell technology.
As a worldwide network, Global Stem Cells Group combines six major medical corporations, each focused on furthering the industry’s scientific and technological advancements to lead cutting edge stem cell development, treatments and training, while adhering to the highest medical standards. The combined efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions.”
Did you not read the 8k and the terms of the LOI to complete the RM? They needed to dilute to raise the $300,000 to pay GSCG for the transaction. Furthermore they were methodical about their actions as they didn’t dilute this down to no bid like they COULD have. They instead got what was necessary and dilution has since stopped. So this talk about the AS/OS increase indicating future pps is ridiculous. Please read the DD or continue to believe that it will hit .0001 and keep your bid in at .0001 while the rest of us are enjoying the fruits above a penny in the coming weeks/months.
https://investorshub.advfn.com/boards/m_read_msg.aspx?message_id=150088117
4 support is growing
That is what I am thinking too. They will be back along with those in the sidelines still when the news drops. It literally could be any day now. We just have to hang tight. For all we know it could be done already but they have not had a chance to generate a PR nor file it with the SEC yet
What it appears happened is some pulled their bids down to .0004s and someone else exited their position. But nothing has changed in terms of the company’s pursuits nor the AS/OS. This also may be MM manipulation. We saw a similar move the last time that the price hit .0004 and people were saying it was MAXM. I added at 4 when this happened last time.
TTC* hit .0329 yesterday with the same SS as LAHO and poised to move higher. And it is not a biotech stock like GSCG with a vast foundation in 25 countries of 41 stem cell centers and more coming.
I agree 1000%
Lmao. I couldn’t have said it better myself. LAHO/GSCG has multiple catalysts in the works for those patient enough to hang tight. Give these hardworking folks a chance to bring these things to fruition. They have already said that they are working on the merger and bring the financials and filings current. That was told to us on June 12th and again in this email:
https://investorshub.advfn.com/boards/m_read_msg.aspx?message_id=149837500
https://investorshub.advfn.com/boards/m_read_msg.aspx?message_id=149837261
Wtf. I smell mawn-nay $$$$
That’s really interesting. However I’m sure as soon as you left Benito made a phone call requesting armed security be installed at the front door. They probably think LAHO shareholders are crazy even if they are eager and intrigued as well. Wow.
Here is the truth for those without level 2:
BID .0005 x 222.34 mil
ASK .0006 x 24.95 mil
PRO TIP: Always use level 2 quotes when trading OTC stocks because without it you are going into a sword fight without a sword.
Remember that on 7/10/19, PennyProOTC posted an email that he received from LAHO stating that their focus was on getting financials current with SEC and completing the GSCG acquisition per the LOI.
https://investorshub.advfn.com/boards/m_read_msg.aspx?message_id=149837500
https://investorshub.advfn.com/boards/m_read_msg.aspx?message_id=149837261
Same was said about TTC* and VRU* and others. This s*** is comedy.
$LAHO DD - R/M binding LOI Signed for Lans Holdings to acquire Global Stem Cells Group (GSCG)!
**Reverse Merger asset acquisition definitive agreement expected any day by October 31st! (150 days from May 28th 8K filing of binding LOI)
Comprehensive LAHO DD - https://investorshub.advfn.com/boards/m_read_msg.aspx?message_id=150088117
GSCG has 36 stem cell centers in 27 countries globally, plus the Adimarket which sells products and recently outfits a medical center exclusively. This adds another revenue stream in addition to the work of its centers administering stem cell therapies and training medical professionals, and another way this company can scale and expand within the industry. There are a lot of facets to take in when assessing the potential this company has in a hot, growing sector.
“Global Stem Cells Group was founded in 2010 by Benito Novas, an entrepreneur who became intrigued by advancements being made in the field of stem cell medicine. Determined to make these advancements available to as many patients as possible, Mr. Novas grew GSCG from humble beginnings to the company’s current status as a key player in promoting point of care regenerative medicine therapies worldwide.
Global Stem Cells Group administers a constant flow of knowledge and innovation regarding the role of stem cells in modern medicine. The company’s aim is to accelerate the process of getting promising stem cell research and technology developed into treatments and therapies, and made available to physicians and patients. We focus specifically on stem cell research as a source of potential treatments for a wide range of conditions and diseases—in fact, we strongly believe that stem cell and regenerative medicine protocols are the future of modern medicine. GSCG works closely with patients, educators, physicians, regulators and policy makers to foster engagement and develop materials that promote stem cell technology.
As a worldwide network, Global Stem Cells Group combines six major medical corporations, each focused on furthering the industry’s scientific and technological advancements to lead cutting edge stem cell development, treatments and training, while adhering to the highest medical standards. The combined efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions.”
$$$LAHO DD - Binding LOI Reverse Merger with GSCG - filed as an 8K
****Reverse Merger DD satisfaction statement & asset acquisition definitive agreement expected any day now by October 31st! (150 days from binding LOI filed as an SEC 8k on May 28th)
Comprehensive LAHO DD - https://investorshub.advfn.com/boards/m_read_msg.aspx?message_id=150088117
Comprehensive $LAHO DD - next penny runner:
***Awaiting announcement of return to SEC current status by Sept 12 - (within 90 days from June 12 PR as announced)
***Awaiting Reverse Merger filing of asset acquisition definitive agreement expected before October 31st (150 days from the May 29th binding LOI 8k filed)
—————————————————-
REVERSE MERGER ANNOUNCEMENT
Lans Holdings Enters into Binding LOI to Acquire Global Stem Cells Group (GSCG)
https://globenewswire.com/news-release/2019/05/28/1853115/0/en/Lans-Holdings-Enters-into-Binding-LOI-to-Acquire-Global-Stem-Cells-Group.html
SEC FORM 8K (Binding LOI to acquire GSCG)
https://www.otcmarkets.com/filing/html?id=13457482&guid=
GSCG has 41 stem cell centers in 25 countries globally, plus the Adimarket which sells stem cell proprietary technology and products and recently outfitted a medical center exclusively. This adds another revenue stream in addition to the work of its centers administering stem cell therapies and training medical professionals, and another way this company can scale and expand within the industry. There are a lot of facets to take in when assessing the potential this company has in a hot, growing sector.
Benito Novas of Aesthetica Marketing Group Set as Keynote for Chilean Aesthetics Congress (JULY 17, 2019)
http://www.stemcellsgroup.com/adimarket-llc-launches-new-product-for-physicians-seeking-to-create-regenerative-medicine-and-stem-cell-treatment-centers-2/
Adimarket, LLC Launches New Product for Physicians Seeking to Create Regenerative Medicine and Stem Cell Treatment Centers (JULY 17, 2019)
http://www.stemcellsgroup.com/adimarket-llc-launches-new-product-for-physicians-seeking-to-create-regenerative-medicine-and-stem-cell-treatment-centers/
GSCG: Stem Cells Group to Host Regenerative Medicine Symposium at the University of Miami (June 26, 2019)
http://www.stemcellsgroup.com/stem-cells-group-to-host-regenerative-medicine-symposium-at-the-university-of-miami/
GSCG: Global Stem Cells Group to Host Argentina Lectures on Newest Stem Cells Therapies (June 26, 2019)
http://www.stemcellsgroup.com/global-stem-cells-group-to-host-argentina-lectures-on-newest-stem-cells-therapies/
GSCG: ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center: The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France. GSCG’s Adimarket store will all provide equipment and supplies to the facility. (June 26, 2019)
http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/
To learn more about Churchill Aesthetic Center, visit https://www.churchill-aesthetic-center.be/. To learn more about ISSCA, visit https://issca.us/
LAHO: Global Stem Cells Group Announces Opening of Two New Stem Cell Centers (June 12, 2019)
https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503
GLOBAL STEM CELLS GROUP WEBSITE--GSCG
http://www.stemcellsgroup.com/
GSCG HAS AN ONLINE STORE FOR REGENERATIVE MEDICINE PRACTITIONERS
GSCG REVENUE ($29 million):
https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775
GSCG--Adimarket - Turn-Key Solution for Regenerative Medicine
https://www.adimarket.net/
Zoominfo says that Adimart, Inc (Adimarket, Inc., a division of the Global Stem Cells Group, is a cost-competitive online marketplace for quality regenerative medicine equipment and supplies) has $10 million in revenue with a breakdown of 2.4 million average quarterly in 2018.
https://www.zoominfo.com/c/adimarket-inc/359689609
Lans Holdings posted a message about the LOI on its Linked in
https://www.linkedin.com/company/lans-holdings-inc?trk=similar-companies_org_title
CEO Benito Novas has some impressive credentials and accolades
https://www.linkedin.com/in/benito-novas-671a4122?trk=org-employees_mini-profile_title
Here’s the YouTube channel for GSCG (videos of CEO speaking, conferences, explanations of the company and its processes, etc)
https://www.youtube.com/user/StemCellsGroup
Listen to what you just said. Please
Oh yea? Then why does the bid keep increasing? Too much comedy here. This will be in multiple pennies before end of year.
Who doubted they were active? Lol
I’ve tended to find that OTC stocks, with message boards full of “bashers,” tend to mean the stock is good. Why? Flipping and shorting are possible, because there is demand from retail buyers. The same “bashers” don’t waste their time on stock message boards when the stocks have no potential.
Just my opinion and observations. Much good for the future of LAHO.
Very true. Bid is growing and MMs appear to be migrating to .001+. Sign?